Drug-Eluting Vascular Stent System

Laser-cut nitinol stent purpose-built for the SFA with flexibility, strength and fracture resistance



Flexibility is important in the SFA because of the unique and complex mechanical movements in the vessel. The SFA requires a purpose-built stent with the ability to track through tortuous, dynamic anatomy and conform to the vessel.
The Eluvia Stent was engineered for flexibility with an open cell design along the stent body.
SFA open cell flexible stent
Eluvia Stent's open cell design
Peak to valley design SFA stent
Eluvia Stent's peak-to-valley design
The offset strut peaks (peak-to-valley design) enhances conformability, axial flexibility and kink resistance.


The Eluvia Stent provides the strength necessary to stay open within the challenging and dynamic SFA. Outward radial force allows the stent to fully open, while strong compression resistance enables the stent to maintain lumen diameter even during vessel movement and external pressure. 

The Eluvia Stent architecture was designed to optimize outward radial force and compression resistance and provide balanced stress distribution and strength.

Eluvia Stent struts, width, length and angles
The Eluvia Stent is designed to optimize outward radial force to fully open and compression resistance to maintain lumen diameter

Fracture Resistance

The SFA is subject to unique mechanical forces like compression and bending, which cause fatigue fractures in stents.

The Eluvia Stent is designed to withstand multiple deformation modes including elongation, extreme bending and axial compression, through a balanced spacing of strut connectors.

Custom materials and processing practices, including high purity nitinol and enhanced stent polishing, create excellent fatigue resistance for the Eluvia Stent.

SFA mechanical force resistance stent
The Eluvia Stent is designed to provide balanced stress distribution and strength
Product Overview

Product Overview

Advanced drug-eluting technology for peripheral artery disease.

Clinical Programs

Clinical Programs

Unprecedented clinical outcomes in the SFA.

Sustained Drug Release

Sustained Drug Release

Delivers paclitaxel when restenosis is most likely to occur.